Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G, Belvedere O, Aita M, Zanin T, Follador A, Cassetti P, Meduri S, De Pangher V, Pignata G, Rosolen V, Barbone F, Grossi F. Fasola G, et al. Among authors: rosolen v. Oncologist. 2007 Oct;12(10):1215-24. doi: 10.1634/theoncologist.12-10-1215. Oncologist. 2007. PMID: 17962615 Free article.
Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.
Castellsague J, Pisa F, Rosolen V, Drigo D, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Castellsague J, et al. Among authors: rosolen v. Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):365-75. doi: 10.1002/pds.3385. Epub 2012 Dec 11. Pharmacoepidemiol Drug Saf. 2013. PMID: 23229866
Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy.
Pisa F, Castellsague J, Drigo D, Riera-Guardia N, Giangreco M, Rosolen V, Clagnan E, Zanier L, Perez-Gutthann S, Barbone F. Pisa F, et al. Among authors: rosolen v. Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1195-204. doi: 10.1002/pds.3504. Epub 2013 Aug 20. Pharmacoepidemiol Drug Saf. 2013. PMID: 23959537
Prenatal mercury exposure and child neurodevelopment outcomes at 18 months: Results from the Mediterranean PHIME cohort.
Barbone F, Rosolen V, Mariuz M, Parpinel M, Casetta A, Sammartano F, Ronfani L, Vecchi Brumatti L, Bin M, Castriotta L, Valent F, Little DL, Mazej D, Snoj Tratnik J, Miklavčič Višnjevec A, Sofianou K, Špirić Z, Krsnik M, Osredkar J, Neubauer D, Kodrič J, Stropnik S, Prpić I, Petrović O, Vlašić-Cicvarić I, Horvat M. Barbone F, et al. Among authors: rosolen v. Int J Hyg Environ Health. 2019 Jan;222(1):9-21. doi: 10.1016/j.ijheh.2018.07.011. Epub 2018 Jul 26. Int J Hyg Environ Health. 2019. PMID: 30057028
48 results